This is a $11,926.98 firm fixed price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC for the delivery of medical supplies. The award has no set-aside designation and has a period of performance through February 2025. Biofire Defense LLC is a manufacturer of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems, and has previously received prime and subcontract awards from the Department of Defense, Department of State, National Institutes of Health, and other federal agencies for the provision of diagnostic assays, test kits, and testing platforms related to biodefense, infectious disease testing, and COVID-19 response. The company has also been awarded a $6.2 million cooperative agreement from the Department of Defense's Washington Headquarters Service to expand manufacturing capacity for Department of Defense COVID test kit production, and holds a separate $18.8 million indefinite delivery contract from the Army's Acquisition Support Center Chemical and Biological Defense organization for sustainment of the Next Generation Diagnostic System.
Generated 3/12/25, 9:58 AM